Transcept Pharmaceuticals (TSPT)
Transcept Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 12.82M | 0.625M | 3.125M | 3.125M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 12.82M | 0.625M | 3.125M | 3.125M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Research & Development Expense | 2.357M | 3.351M | 2.668M | 2.763M | 2.491M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 2.784M | 4.14M | 2.919M | 2.582M | 2.544M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 5.141M | 7.491M | 5.587M | 5.345M | 5.035M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -5.141M | 5.328M | -4.962M | -2.22M | -1.91M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -0.036M | -0.032M | -0.029M | -0.026M | -0.029M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -5.177M | 5.296M | -4.991M | -2.246M | -1.939M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income after Tax | -5.177M | 5.296M | -4.991M | -2.246M | -1.939M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -5.177M | 5.296M | -4.991M | -2.246M | -1.939M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -5.177M | 5.296M | -4.991M | -2.246M | -1.939M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 13.92 | 13.53 | 13.52 | 13.49 | 13.46 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 13.92 | 13.53 | 13.52 | 13.49 | 13.46 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.37 | 0.39 | -0.37 | -0.17 | -0.14 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.37 | 0.39 | -0.37 | -0.17 | -0.14 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
